Idiopathic pulmonary fibrosis (IPF) cases linked with asbestos exposure
Munich, Germany: A proportion of idiopathic pulmonary fibrosis (IPF) cases may be linked with asbestos exposure, according to the results of a new study. If confirmed, the findings would mean that current treatment strategies need to be altered as people with a history of asbestos exposure are not currently able to access new treatments for IPF.
The research, which was presented at the European Respiratory Society’s International Congress today (09 September 2014), provided new mortality data for IPF, asbestosis and mesothelioma.
Asbestosis is the name given to the lung disease developed by people with a known history of exposure to asbestos. The symptoms and presentation of this disease can be identical to IPF; the only difference between the two diseases is whether a patient knows about their exposure to asbestos. People with asbestosis are not currently eligible for new treatments for IPF, despite the fact that these treatments work on curing an identical disease.
Researchers have suggested that a proportion of IPF may be due to unknown exposure to asbestos. They analysed mortality rates for IPF, asbestosis and mesothelioma across England and Wales. Data were obtained from the Office of National Statistics on the annual number of deaths due to IPF, mesothelioma and asbestos for the period 1974–2012, broken down by age, sex and region.
The analysis revealed national and regional correlations between the three diseases, which supports the theory that a proportion of IPF cases are due to unknown exposure to asbestos. If this asbestos exposure was known, it would be likely that these patients were diagnosed with asbestosis rather than IPF.
There were also high rates of IPF deaths in particular regions in the North West and South East of England, which has a history of shipyard work and therefore potential exposure to asbestos dust.
Lead researcher, Dr Carl Reynolds from Imperial College London, said: “The findings are consistent with the hypothesis that a proportion of IPF cases are likely to be caused by unknown exposure to asbestos. More research is needed in this area, particularly as patients known to have asbestos exposure are not currently considered to be candidates for new treatments for IPF and this may be inappropriate.”
Notes to editors:
- Abstract: Idiopathic Pulmonary Fibrosis, asbestosis and mesothelioma, trends for England and Wales: is asbestos exposure associated with IPF?
- Session: Occupational, indoor and outdoor environments and COPD
- Date and time: Tuesday 9 September, 08.30-09.30
- Room: A2-2
This year’s ERS Congress will see the launch of Healthy Lungs for Life; one of the largest ever lung health campaigns, raising awareness of the importance of healthy lungs through a full range of events, projects and promotional activities.
In 2014, the theme is "Breathe clean air". Clean air means air free from particulate matter, pathogens, smoke and dangerous gases. We all have little control over the air that we breathe, but learning more about the quality of air and its impact can help people to find the best way to protect themselves. Find out more: www.healthylungsforlife.org